Transforming Hydrogel Sterilization: Vivos Inc's Breakthrough
Vivos Inc. has recently made a significant stride in innovative healthcare solutions by filing a provisional patent for a revolutionary hydrogel sterilization technique. This process leverages electron beam (E-Beam) technology, which has undergone extensive testing to ensure its efficacy and safety.
Validating the E-Beam Sterilization Process
After nearly a year of rigorous testing, Vivos Inc has validated this advanced sterilization method under the standards set by ISO 11137, a respected international benchmark in the medical device field. This testing was essential to confirm the viability of the E-Beam technology, particularly suited for the unique properties of Vivos’s proprietary hydrogel.
Reliability and Safety Standards
The results indicate that the E-Beam sterilization process is not only reproducible but also offers a higher reliability compared to traditional filtration methods. It achieves an impressive sterility assurance level of 10-6, reflecting an extremely low probability of microorganism survival. This level of assurance is crucial for ensuring patient safety, especially for critical medical devices.
Benefits Beyond Sterilization
Beyond enhancing safety, the E-Beam sterilization process brings additional benefits, including cost-effectiveness, improved production yield, and enhanced scalability. These advantages are paving the way for Vivos to expand its market reach and effectively distribute sterile hydrogel and PrecisionGel globally.
Supporting Veterinary Demand
This innovative approach will also significantly benefit Vivos's animal health product, IsoPet®. By streamlining the manufacturing process, Vivos can ensure a consistent supply that meets the rising demands within the veterinary sector. This dual focus on human and animal health not only enhances revenue prospects but strengthens Vivos’s competitive edge in a crowded marketplace.
Leadership Insights
Michael K. Korenko, Sc.D., President & CEO of Vivos Inc, emphasizes that this breakthrough aligns with Vivos’s commitment to providing cutting-edge health solutions. Their strategic direction involves leveraging intellectual property such as this new patent to secure a stronger foothold in both human and veterinary medicine.
For further inquiries or to learn more about their innovative products, interested parties can reach out directly via email: MKorenko@RadioGel.com. Additionally, you can follow Vivos Inc on social media, specifically on X (formerly Twitter) under @VivosIncUSA.
Frequently Asked Questions
What is the focus of Vivos Inc's new patent?
The patent focuses on a new method for sterilizing hydrogel using an electron beam process, improving safety and efficacy.
How does the E-Beam process compare to traditional methods?
The E-Beam process offers greater reliability and a higher sterility assurance level compared to conventional sterilization techniques.
What impact does this patent have on veterinary health?
This innovation enhances the manufacturing of IsoPet®, ensuring it meets the growing demand in the veterinary industry.
Who is the leader of Vivos Inc.?
The company is led by Michael K. Korenko, Sc.D., who plays a pivotal role in driving its innovation strategies.
How can I learn more about Vivos Inc's products?
More information about Vivos Inc's products like RadioGel® and IsoPet® can be found on their official website, www.VivosInc.com.
